174 related articles for article (PubMed ID: 36221980)
21. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
22. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
[TBL] [Abstract][Full Text] [Related]
23. Role of neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios as predictors of disease severity in COVID-19 patients.
Kalabin A; Mani VRK; Valdivieso SC; Donaldson B
Infez Med; 2021 Mar; 29(1):46-53. PubMed ID: 33664172
[TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory features of COVID-19: Predictors of severe prognosis.
Bastug A; Bodur H; Erdogan S; Gokcinar D; Kazancioglu S; Kosovali BD; Ozbay BO; Gok G; Turan IO; Yilmaz G; Gonen CC; Yilmaz FM
Int Immunopharmacol; 2020 Nov; 88():106950. PubMed ID: 32919217
[TBL] [Abstract][Full Text] [Related]
25. Characterization of coagulopathy and outcomes in cancer patients with severe COVID -19 illness: Longitudinal changes in hospitalized cancer patients.
Madani M; Goldstein D; Stefanescu R; Woodman SE; Rojas-Hernandez CM
Cancer Med; 2022 Oct; 11(20):3771-3785. PubMed ID: 35470980
[TBL] [Abstract][Full Text] [Related]
26. Effect of first application laboratory values on the prognosis of COVID-19 patients hospitalized in the intensive care unit.
Corapli G; Çil E; Tutak AŞ; Corapli M
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3361-3366. PubMed ID: 35587089
[TBL] [Abstract][Full Text] [Related]
27. Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.
Nugroho J; Wardhana A; Maghfirah I; Mulia EPB; Rachmi DA; A'yun MQ; Septianda I
Int J Lab Hematol; 2021 Feb; 43(1):110-115. PubMed ID: 32931146
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
[TBL] [Abstract][Full Text] [Related]
29. The predictive role of biomarkers for mortality in COVID-19 patients.
Savrun A; Aydin IE; Savrun ST; Karaman U
Trop Biomed; 2021 Sep; 38(3):366-370. PubMed ID: 34508345
[TBL] [Abstract][Full Text] [Related]
30. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.
Saji R; Nishii M; Sakai K; Miyakawa K; Yamaoka Y; Ban T; Abe T; Ohyama Y; Nakajima K; Hiromi T; Matsumura R; Suzuki N; Taniguchi H; Otsuka T; Oi Y; Ogawa F; Uchiyama M; Takahashi K; Iwashita M; Kimura Y; Fujii S; Furuya R; Tamura T; Ryo A; Takeuchi I
PLoS One; 2021; 16(8):e0256022. PubMed ID: 34379684
[TBL] [Abstract][Full Text] [Related]
31. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
[TBL] [Abstract][Full Text] [Related]
32. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
33. Serum Ferritin as a Predictor of Outcomes in Hospitalized Patients with Covid-19 Pneumonia.
Shakaroun DA; Lazar MH; Horowitz JC; Jennings JH
J Intensive Care Med; 2023 Jan; 38(1):21-26. PubMed ID: 35815883
[No Abstract] [Full Text] [Related]
34. Presepsin as a Novel Biomarker in predicting In-hospital Mortality in Patients With COVID-19 Pneumonia.
Assal HH; Abdelrahman SM; Abdelbasset MA; Abdelaziz M; Sabry IM; Shaban MM
Int J Infect Dis; 2022 May; 118():155-163. PubMed ID: 35248717
[TBL] [Abstract][Full Text] [Related]
35. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.
Rastrelli G; Di Stasi V; Inglese F; Beccaria M; Garuti M; Di Costanzo D; Spreafico F; Greco GF; Cervi G; Pecoriello A; Magini A; Todisco T; Cipriani S; Maseroli E; Corona G; Salonia A; Lenzi A; Maggi M; De Donno G; Vignozzi L
Andrology; 2021 Jan; 9(1):88-98. PubMed ID: 32436355
[TBL] [Abstract][Full Text] [Related]
36. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
[TBL] [Abstract][Full Text] [Related]
37. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of biomarker levels and chest imaging in patients with COVID-19 presenting to the emergency department.
Dagher GA; Ghanem AA; Haidar S; Kattouf N; Assaf M; Khdhir M; Chahine R; Rizk J; Makki M; Tamim H; Chebl RB
Am J Emerg Med; 2022 Sep; 59():15-23. PubMed ID: 35772223
[TBL] [Abstract][Full Text] [Related]
39. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
[TBL] [Abstract][Full Text] [Related]
40. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
